What is the antibiotic of choice for a patient with an eye infection?

Antibiotic Choice for Eye Infections

For bacterial conjunctivitis, use topical moxifloxacin 0.5% or gatifloxacin 0.5% (fourth-generation fluoroquinolones) three times daily for 4-5 days, as these agents provide superior gram-positive coverage compared to earlier fluoroquinolones and achieve clinical cure rates of 66-69%. 1, 2

Treatment Algorithm by Infection Type

Bacterial Conjunctivitis (Most Common)

Mild to Moderate Cases:

• First-line: Topical moxifloxacin 0.5% or gatifloxacin 0.5% three times daily for 4-5 days 1
• Alternative FDA-approved options: Levofloxacin 1.5%, ofloxacin 0.3%, or ciprofloxacin 0.3% 1
• WHO-endorsed alternatives: Topical gentamicin, tetracycline, or ofloxacin 3

Severe/Purulent Cases (especially contact lens wearers):

• Topical fourth-generation fluoroquinolone plus consider systemic broad-spectrum antibiotics 3

Special Pathogen Considerations:

• Suspected MRSA: Use topical vancomycin (fortified) as fluoroquinolones are poorly effective against MRSA (42% of staphylococcal isolates show methicillin resistance with concurrent fluoroquinolone resistance) 1, 4, 5
• Gonococcal conjunctivitis: Systemic antibiotics are mandatory in addition to topical therapy 3, 5
• Neonatal chlamydial conjunctivitis: Oral erythromycin (96% clinical cure rate) or azithromycin for 3 days 3
• Trachoma: Single-dose oral azithromycin or topical azithromycin/tetracycline 3

Bacterial Keratitis (Corneal Ulcer)

Small, Non-Central Ulcers:

• Topical fluoroquinolone monotherapy (moxifloxacin or gatifloxacin preferred) 1, 3
• Dosing: Every 5-15 minutes as loading dose, then hourly 1

Central or Severe Keratitis (>2mm infiltrate, deep stromal involvement, or hypopyon):

• First-line: Fortified combination therapy with cefazolin/tobramycin OR fourth-generation fluoroquinolone 1
• Loading dose every 5-15 minutes, then hourly until improvement 1
• Add cycloplegic agents to decrease pain and prevent synechiae 1, 6

Lesions Near Limbus:

• Consider adding systemic antibiotics to topical therapy 3

Resistant Organisms:

• MRSA keratitis: Topical vancomycin (fortified) 1
• Resistant Pseudomonas: Topical colistin 0.19% 1, 4, 5
• Moraxella: Requires prolonged treatment (mean 41.9 days) despite fluoroquinolone susceptibility 1, 5

Corneal Abrasion (Traumatic/Metal Foreign Body)

• Broad-spectrum topical antibiotic within 24 hours to prevent ulceration 6
• Preferred: Moxifloxacin or gatifloxacin four times daily until complete re-epithelialization 6
• Critical: Do NOT patch the eye or use therapeutic contact lens (increases bacterial keratitis risk) 1, 6

Endophthalmitis

• Intravitreal: Ceftazidime plus vancomycin 3
• Systemic: Ceftriaxone plus vancomycin 3

Critical Resistance Patterns to Consider

Increasing Fluoroquinolone Resistance:

• Overall resistance to moxifloxacin increased from 1996-2015 in long-term studies 1, 4
• Pseudomonas resistance to moxifloxacin rose from 19% (2007) to 52% (2009) in southern India 1, 4
• Risk factors: Recent fluoroquinolone use, hospitalization, recent ocular surgery, advanced age 1, 4

MRSA Considerations:

• Methicillin resistance found in 42% of staphylococcal isolates 1, 4, 5
• Fluoroquinolones (including fourth-generation) are generally poorly effective 1, 4
• MRSA isolates remain susceptible to vancomycin 1

Key Clinical Pearls

Why Fourth-Generation Fluoroquinolones Are Preferred:

• Superior gram-positive coverage compared to ciprofloxacin/ofloxacin 1
• Achieve higher conjunctival tissue concentrations with longer residence times 7
• Require dual-step mutation for resistance development 7
• Moxifloxacin has near-neutral pH (6.8) and is self-preserved without benzalkonium chloride 7
• Clinical cure rates of 66-69% by day 5-6 for conjunctivitis 2

Common Pitfalls to Avoid:

• Do not use topical corticosteroids until infection is ruled out 6
• Do not delay antibiotic initiation beyond 24 hours for traumatic abrasions 6
• Do not use therapeutic contact lenses for contact lens-associated abrasions 1, 6
• Do not assume fluoroquinolones will cover MRSA—they won't 1, 4

Follow-Up Requirements:

• Severe keratitis: Daily follow-up until stable or improving 1
• Standard conjunctivitis: Re-evaluate if no improvement after 7 days 4, 5
• Consider culture and sensitivity if treatment failure occurs 1

Adjunctive Measures:

• Cycloplegics for pain relief in keratitis 1, 6
• Consider S. aureus decolonization (nasopharynx/oropharynx) for recurrent infections 1